Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.
Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6, 2025Exclusive ...
As the cold and flu season is underway, Dr. Straw recommended alternatives for those seeking relief. He suggested nasal sprays containing phenylephrine, which are effective because they bypass the ...